Timothy Anthony Yap
Impact in
- Oncology top 0.1%
- PARP inhibition in cancer therapy
- Cancer Research top 0.5%
- Cancer Genomics and Diagnostics
Papers in
- Oncology 135
- PARP inhibition in cancer therapy 63
- Cancer Immunotherapy and Biomarkers 19
- Cancer-related Molecular Pathways 14
- HER2/EGFR in Cancer Research 13
-
- Cancer Genomics and Diagnostics 48
- Co-authors
- Johann Sebastian De Bono (61 shared papers)Stan B. Kaye (18 shared papers)Patrick Glen Pilie (10 shared papers)Funda Meric‐Bernstam (30 shared papers)Gordon Brent Mills (9 shared papers)Filip Jankú (7 shared papers)Mark J. O’Connor (5 shared papers)Andrew N.J. Tutt (4 shared papers)
- Journals
- Clinical Cancer Research (44 papers)Annals of Oncology (24 papers)Cancer Discovery (13 papers)Journal of Clinical Oncology (12 papers)British Journal of Cancer (11 papers)
- Partner nations
- United StatesUnited KingdomCanada
In The Last Decade
Timothy Anthony Yap
287 papers receiving 20.5k citations
Timothy Anthony Yap's Hit Papers
Peers
Comparison fields: 5 of 146
- Oncology 9.4k
- Cancer Research 3.7k
- Molecular Biology 9.8k
- Pulmonary and Respiratory Medicine 4.1k
- Reproductive Medicine 1.1k
Countries citing papers authored by Timothy Anthony Yap
This map shows the geographic impact of Timothy Anthony Yap's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Timothy Anthony Yap with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Timothy Anthony Yap more than expected).
Fields of papers citing papers by Timothy Anthony Yap
This network shows the impact of papers produced by Timothy Anthony Yap. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Timothy Anthony Yap. The network helps show where Timothy Anthony Yap may publish in the future.
Co-authors
The 25 scholars most cited alongside Timothy Anthony Yap, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 306 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Inhibition of Poly(ADP-Ribose) Polymerase in Tumors from BRCA Mutation Carriers Hit paper breakdown → | 2009 | 3057 |
| 2 | State-of-the-art strategies for targeting the DNA damage response in cancer Hit paper breakdown → | 2018 | 911 |
| 3 | Targeting the PI3K pathway in cancer: are we making headway? Hit paper breakdown → | 2018 | 851 |
| 4 | Poly(ADP)-Ribose Polymerase Inhibition: Frequent Durable Responses in BRCA Carrier Ovarian Cancer Correlating With Platinum-Free Interval Hit paper breakdown → | 2010 | 849 |
| 5 | Phase I Clinical Trial of a Selective Inhibitor of CYP17, Abiraterone Acetate, Confirms That Castration-Resistant Prostate Cancer Commonly Remains Hormone Driven Hit paper breakdown → | 2008 | 746 |
| 6 | Targeting DNA Repair in Cancer: Beyond PARP Inhibitors Hit paper breakdown → | 2016 | 499 |
| 7 | 2011 | 491 | |
| 8 | PARPi Triggers the STING-Dependent Immune Response and Enhances the Therapeutic Efficacy of Immune Checkpoint Blockade Independent of BRCAness Hit paper breakdown → | 2018 | 490 |
| 9 | 2008 | 475 | |
| 10 | 2012 | 434 | |
| 11 | 2009 | 315 | |
| 12 | 2010 | 313 | |
| 13 | 2019 | 287 | |
| 14 | 2017 | 273 | |
| 15 | Complex I inhibitor of oxidative phosphorylation in advanced solid tumors and acute myeloid leukemia: phase I trials Hit paper breakdown → | 2023 | 269 |
| 16 | 2013 | 268 | |
| 17 | Development of Immunotherapy Combination Strategies in Cancer Hit paper breakdown → | 2021 | 267 |
| 18 | 2010 | 243 | |
| 19 | 2018 | 235 | |
| 20 | 2007 | 221 |
About Timothy Anthony Yap
Timothy Anthony Yap is a scholar working on Oncology, Cancer Research, Pulmonary and Respiratory Medicine, Molecular Biology and Statistics and Probability, having authored 306 papers that have together received 20.9k indexed citations. Recurring topics across this work include PARP inhibition in cancer therapy (63 papers), Cancer Genomics and Diagnostics (48 papers), DNA Repair Mechanisms (40 papers), Lung Cancer Treatments and Mutations (26 papers), PI3K/AKT/mTOR signaling in cancer (24 papers), Cancer Immunotherapy and Biomarkers (19 papers), Cancer-related Molecular Pathways (14 papers) and HER2/EGFR in Cancer Research (13 papers). The work is most often cited by research in Oncology (9.4k citations), Cancer Research (3.7k citations), Molecular Biology (9.8k citations), Pulmonary and Respiratory Medicine (4.1k citations) and Reproductive Medicine (1.1k citations). Timothy Anthony Yap has collaborated with scholars based in United States, United Kingdom and Canada. Frequent co-authors include Johann Sebastian De Bono, Stan B. Kaye, Patrick Glen Pilie, Funda Meric‐Bernstam, Gordon Brent Mills, Filip Jankú, Mark J. O’Connor, Andrew N.J. Tutt, Paul Workman and Jan H.M. Schellens. Their work appears in journals such as Clinical Cancer Research, Annals of Oncology, Cancer Discovery, Journal of Clinical Oncology and British Journal of Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.